WE ARE GATEHOUSE BIO
We believe there is an RNA code that drives every disease
- Our mission is to find that code and use it to develop effective therapeutics
- Our Code-Breakerâ„¢ platform uses AI to decode the landscape of small RNAs (sRNAs) and digitally design biomarker-guided precision oligonucleotide therapeutics
- We are currently developing our lead targets into therapies to treat pulmonary, cardiac, neurological, and autoimmune diseases
With every single code we break, we unlock the potential to improve the lives of many
research Collaborations
We are seeking researchers that who are discovering biomarkers, hunting for novel drug targets or exploring disease to better understand biology.
Contact us to learn more about sRNA and Code-Breakerâ„¢.
Business Development
It takes an ecosystem of interdisciplinary experts to bring new precision medicines from discovery to the clinic. We are seeking partners to co-develop precision medicines and integrate Code-Breaker into their discovery pipeline. Our data has demonstrated application across multiple therapeutic areas.
Contact us to learn more.
Investors
The future of precision sRNA medicine will be realized through continued use of Code-Breaker to learn and predict complex mRNA :: sRNA activity relationships and design therapeutics. Our next major milestone is to bring our first lead through human clinical trials; we will accomplish this goal with an ecosystem that we have been developing over the last 4 years. We are seeking investors to help expand our potential.
Contact us to learn more about our traction and plans.